@article{c2768fa4406b49968680e34353171d27,
title = "Moving to fingolimod from natalizumab in multiple sclerosis: the ENIGM is not solved",
abstract = "No abstract available",
keywords = "Antibodies, Monoclonal, Humanized, Drug Substitution, Female, Humans, Immunosuppressive Agents, Male, Multiple Sclerosis, Propylene Glycols, Sphingosine, Antibodies, Monoclonal, Humanized, Drug Substitution, Female, Humans, Immunosuppressive Agents, Male, Multiple Sclerosis, Propylene Glycols, Sphingosine",
author = "Assunta Bianco and Rossini, {Paolo Maria} and Massimiliano Mirabella",
year = "2014",
doi = "10.1001/jamaneurol.2014.1135",
language = "English",
volume = "71",
pages = "924--925",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "American Medical Association",
}